5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.10%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-23.17%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-51.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-51.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-70.84%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-70.53%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-70.53%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.28%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.28%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-87.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-152.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-17.85%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-5.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
2.58%
3Y revenue/share CAGR similar to METSB.HE's 2.58%. Walter Schloss would assume both companies experience comparable short-term cycles.
449.55%
10Y OCF/share CAGR in line with METSB.HE's 449.55%. Walter Schloss would see both as similarly efficient over the decade.
-57.69%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-78.98%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6.73%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-53.37%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-62.69%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
94.40%
10Y equity/share CAGR in line with METSB.HE's 94.40%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
58.86%
5Y equity/share CAGR is in line with METSB.HE's 58.86%. Walter Schloss would see parallel mid-term profitability and retention policies.
46.18%
3Y equity/share CAGR similar to METSB.HE's 46.18%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
866.68%
Similar 10Y dividend/share CAGR to METSB.HE's 866.68%. Walter Schloss expects both to share consistent earnings expansions and payout practices.
202.74%
Similar 5Y dividend/share CAGR to METSB.HE's 202.74%. Walter Schloss sees parallel philosophies in mid-term capital returns.
162.32%
3Y dividend/share CAGR similar to METSB.HE's 162.32%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-14.09%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.68%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.10%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.73%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.42%
Debt growth far above METSB.HE's 0.42%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
8.01%
SG&A growth well above METSB.HE's 8.01%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.